Marubeni Construction Material Lease Co.,Ltd. Logo

Marubeni Construction Material Lease Co.,Ltd.

Leases and sells temporary steel materials and offers engineering for major construction projects.

9763 | T

Overview

Corporate Details

ISIN(s):
JP3878000003
LEI:
Country:
Japan
Address:
港区芝公園2丁目4番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Marubeni Construction Material Lease Co., Ltd. specializes in the leasing, sale, repair, and processing of temporary steel materials for the construction industry. The company's core product portfolio includes sheet piles, H-beams, steel supports, and steel decks. In addition to material provision, its engineering division offers planning and design services for temporary steel structures. The firm primarily supports the development of urban infrastructure and large-scale construction projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 02:19
Interim Report
確認書
Japanese 9.8 KB
2025-11-11 02:18
Interim Report
半期報告書-第58期(2025/04/01-2025/09/30)
Japanese 211.2 KB
2025-06-23 06:28
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-18 05:01
Registration Form
確認書
Japanese 10.1 KB
2025-06-18 05:00
Governance Information
内部統制報告書-第57期(2024/04/01-2025/03/31)
Japanese 28.5 KB
2025-06-18 04:59
Annual Report
有価証券報告書-第57期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 05:08
Interim Report
確認書
Japanese 9.4 KB
2024-11-12 05:06
Interim Report
半期報告書-第57期(2024/04/01-2025/03/31)
Japanese 205.8 KB
2024-06-21 02:39
Post-Annual General Meeting Information
臨時報告書
Japanese 25.4 KB
2024-06-20 06:56
Registration Form
確認書
Japanese 9.5 KB
2024-06-20 06:55
Governance Information
内部統制報告書-第56期(2023/04/01-2024/03/31)
Japanese 24.8 KB
2024-06-20 06:31
Registration Form
有価証券報告書-第56期(2023/04/01-2024/03/31)
Japanese 1.1 MB
2024-02-09 03:40
Quarterly Report
確認書
Japanese 9.4 KB
2024-02-09 03:39
Quarterly Report
四半期報告書-第56期第3四半期(2023/10/01-2023/12/31)
Japanese 182.3 KB
2023-11-13 05:18
Quarterly Report
確認書
Japanese 9.4 KB

Automate Your Workflow. Get a real-time feed of all Marubeni Construction Material Lease Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Marubeni Construction Material Lease Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Marubeni Construction Material Lease Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.